<DOC>
	<DOCNO>NCT01224327</DOCNO>
	<brief_summary>The purpose study investigate efficacy umbilical cord mesenchymal stem cell ( MSCs ) infusion via hepatic artery treatment liver cirrhosis .</brief_summary>
	<brief_title>Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery Cirrhosis Patients</brief_title>
	<detailed_description>To investigate efficacy umbilical cord mesenchymal stem cell ( MSCs ) infusion via hepatic artery treatment liver cirrhosis . Patients liver cirrhosis randomly separate two group . Umbilical cord MSCs infuse patient use interventional method via hepatic artery One group . After catheter place proper hepatic artery confirm angiography , umbilical cord MSCs infuse slowly 15-20minutes . The control group accept conserved therapy .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Aged 18~70 year . Liver cirrhosis write consent The endstage liver cirrhosis . Severe problem vital organ ( e.g.the heart , renal lung ) . Hepatocellular carcinoma malignancy Pregnancy sepsis Presence significant extrahepatic biliary disease ( e.g . CBD stone , PSC , etc . ) Cardiac , renal respiratory failure Active thrombosis portal hepatic vein</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Liver cirrhosis</keyword>
	<keyword>Radiology</keyword>
	<keyword>Mesenchymal Stem Cells</keyword>
	<keyword>Umbilical Cord</keyword>
</DOC>